Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.720
+0.035 (0.75%)
Oct 27, 2026, 11:45 AM CET
Faes Farma Revenue
Faes Farma had revenue of 200.93M EUR in the quarter ending June 30, 2026, with 31.44% growth. This brings the company's total for the last twelve months to 728.59M, up 33.69% year-over-year. In the year 2025, Faes Farma had annual revenue of 632.47M with 22.53% growth. That makes Faes Farma the 8,729th largest company in the world by revenue and 66th in Spain.
Revenue (ttm)
728.59M
Revenue Growth
+33.69%
P/S Ratio
2.05
Revenue / Employee
272.33K
Employees
2,611
Market Cap
1.47B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Faes Farma breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 632.47M | 116.31M | 22.53% |
| Dec 31, 2024 | 516.15M | 39.23M | 8.23% |
| Dec 31, 2023 | 476.92M | 22.63M | 4.98% |
| Dec 31, 2022 | 454.29M | 36.25M | 8.67% |
| Dec 31, 2021 | 418.05M | 4.35M | 1.05% |
| Dec 31, 2020 | 413.70M | 26.85M | 6.94% |
| Dec 31, 2019 | 386.85M | 42.41M | 12.31% |
| Dec 31, 2018 | 344.44M | 64.83M | 23.18% |
| Dec 31, 2017 | 279.61M | 39.55M | 16.48% |
| Dec 31, 2016 | 240.06M | 23.78M | 11.00% |
| Dec 31, 2015 | 216.28M | 76.85M | 55.12% |
| Dec 31, 2014 | 139.43M | -53.03M | -27.55% |
| Dec 31, 2013 | 192.46M | 3.43M | 1.81% |
| Dec 31, 2012 | 189.03M | -5.29M | -2.72% |
| Dec 31, 2011 | 194.31M | -22.24M | -10.27% |
| Dec 31, 2010 | 216.55M | 15.67M | 7.80% |
| Dec 31, 2009 | 200.89M | 1.69M | 0.85% |
| Dec 31, 2008 | 199.20M | -6.70M | -3.25% |
| Dec 31, 2007 | 205.90M | 12.86M | 6.66% |
| Dec 31, 2006 | 193.03M | 26.09M | 15.63% |
| Dec 31, 2005 | 166.94M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.42B |
| Almirall | 1.16B |
| Laboratorios Farmaceuticos Rovi | 773.05M |
| Laboratorio Reig Jofre | 337.73M |
| Clínica Baviera | 320.67M |
| Prim, S.A. | 250.65M |
| Pharma Mar | 218.64M |
| Atrys Health | 147.68M |
Faes Farma News
- 2 months ago - Faes Farma Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Faes Farma Slides: Q2 2026 - Filings
- 2 months ago - Faes Farma Earnings release: Q2 2026 - Filings
- 2 months ago - Faes Farma Quarterly report: Q2 2026 - Filings
- 6 months ago - Faes Farma Earnings Call Transcript: Q1 2026 - Transcripts
- 6 months ago - Faes Farma Slides: Q1 2026 - Filings
- 6 months ago - Faes Farma Earnings release: Q1 2026 - Filings
- 8 months ago - Faes Farma Earnings Call Transcript: Q4 2025 - Transcripts